Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCORT-DM: Cilostazol vs Aspirin in Type 2 Diabetes
NCT02933788Phase 4Unknown
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of cilostazol in type 2 diabetes mellitus (T2DM), sponsored by Kangbuk Samsung Hospital. Primary endpoint: Platelet reactivity testing at 14 days. Status: unknown.
02
Drugs
cilostazol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02933788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933788.